- Home
- SILO vs CSCI Comparison
SILO vs CSCI Comparison
Compare SILO & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SILO
- CSCI
- Stock Information
- Founded
- SILO 2010
- CSCI 1990
- Country
- SILO United States
- CSCI Canada
- Employees
- SILO N/A
- CSCI N/A
- Industry
- SILO Apparel
- CSCI
- Sector
- SILO Consumer Discretionary
- CSCI
- Exchange
- SILO Nasdaq
- CSCI NYSE
- Market Cap
- SILO 8.8M
- CSCI 9.9M
- IPO Year
- SILO N/A
- CSCI 1996
- Fundamental
- Price
- SILO $0.52
- CSCI $3.34
- Analyst Decision
- SILO
- CSCI
- Analyst Count
- SILO 0
- CSCI 0
- Target Price
- SILO N/A
- CSCI N/A
- AVG Volume (30 Days)
- SILO 561.7K
- CSCI 4.3K
- Earning Date
- SILO 05-09-2025
- CSCI 05-13-2025
- Dividend Yield
- SILO N/A
- CSCI N/A
- EPS Growth
- SILO N/A
- CSCI N/A
- EPS
- SILO N/A
- CSCI N/A
- Revenue
- SILO $72,102.00
- CSCI $9,030,000.00
- Revenue This Year
- SILO $1.86
- CSCI N/A
- Revenue Next Year
- SILO N/A
- CSCI N/A
- P/E Ratio
- SILO N/A
- CSCI N/A
- Revenue Growth
- SILO N/A
- CSCI 127.46
- 52 Week Low
- SILO $0.72
- CSCI $1.96
- 52 Week High
- SILO $4.50
- CSCI $11.10
- Technical
- Relative Strength Index (RSI)
- SILO 31.21
- CSCI N/A
- Support Level
- SILO $0.71
- CSCI N/A
- Resistance Level
- SILO $1.13
- CSCI N/A
- Average True Range (ATR)
- SILO 0.12
- CSCI 0.00
- MACD
- SILO -0.00
- CSCI 0.00
- Stochastic Oscillator
- SILO 5.96
- CSCI 0.00
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. The Company has two reportable and operating segments: Active ingredient and Biopharmaceutical.